XBI
- SPDR S&P Biotech ETFKey Information
| Earliest date | 2006-02-06 |
| Exchange | NYSE |
| Instrument Type | ETF |
| MIC Code | ARCX |
| Country | United States |
ETF Information
| Fund Provider | State Street |
| Index | S&P Biotechnology Select Industry |
| Expense Ratio | 0.35% |
| Number Of Holdings | 140 |
| Inception Date | 2006-01-31 |
| Asset Class | Equity |
| Listing | US-listed |
| Sector | Healthcare |
| Investment Style | Growth |
| Non-leveraged | Non-leveraged |
About XBI
The SPDR S&P Biotech ETF (XBI) provides exposure to the biotechnology sector in the United States, offering a diversified portfolio of mid-cap and small-cap securities. The fund tracks the S&P Biotechnology Select Industry Index, using an equal-weighted methodology to balance assets across all components. This ETF is suitable for investors seeking to fine-tune their exposure to the health care sector or those bullish on biotechnology over the long run.